EMA starts review of Tavneos, a medicine for rare autoimmune diseases GPA and MPA - European Medicines Agency (EMA)

30 Jan 20264 min read0 viewsAgency Feed

GIST

EMA starts review of Tavneos, a medicine for rare autoimmune diseases GPA and MPA European Medicines Agency (EMA)

Clinical Editorial

Summary

EMA (European Medicines Agency) News published a clinical update in Pharmacology on 30 Jan 2026. The item focuses on EMA starts review of Tavneos, a medicine for rare autoimmune diseases GPA and MPA - European Medicines Agency (EMA). Open the detail page to review the full original feed content.